Annovis publishes alzheimer's drug trial results in Nature journal

April 28, 2026 8:01 AM

Annovis Bio Inc. (NYSE: ANVS) announced the publication of its Phase 2/3 Alzheimer's disease trial results for buntanetap in the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found